Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning, today we look at ...
Gameto Announces FDA IND Clearance for Fertilo, the First iPSC-Based Therapy to Enter U.S. Phase 3 Clinical Trials ...
The FDA accepted applications for a golimumab biosimilar, while Samsung Biologics reported record sales, and a Japanese ...
Achieved Statistical Significance with Up to 48% Slowing of Clinical Progression on UMSARS Rating Scale - MELBOURNE, Australia and SAN FRANCISCO, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Alterity ...
Scholar Rock submitted its BLA of apitegromab for the treatment of patients with Spinal Muscular Atrophy with a request for Priority Review to be given. Explore more details here.
The state is a food science hub thanks to all the food company headquarters, including General Mills and Cargill.
Takeda has axed plans to seek approval for its failed epilepsy drug candidate soticlestat. The Japanese drugmaker pulled the plug on the program after the FDA pointed out the shortcomings of its ...
The Cool Down on MSN4h
Scientists make surprising discovery about plants that may transform how we grow food: 'Could help develop new strategies'A groundbreaking discovery about how plants defend themselves against environmental threats could transform the way we grow ...
Driven by rapid innovations and the integration of modern technologies, the biotech sector is experiencing robust growth.
The flight path into Reagan National Airport was busy in the minutes leading up to the collision. Ten aircraft were recorded ...
Hosted on MSN13h
Phase III Trials: It’s crunch time for these ASX health stocksSeveral ASX-listed companies are undertaking phase III clinical trials, the critical final stage before potential regulatory ...
Inc. stock despite strong Phase 2b data. Click for my updated look at MNMD stock and its market opportunities.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback